Outpatient management of uncomplicated lower-extremity infections in diabetic patients
- PMID: 2183732
Outpatient management of uncomplicated lower-extremity infections in diabetic patients
Abstract
Most diabetic foot infections are believed to be caused by both aerobic and anaerobic bacteria and to require hospitalization and parenteral antimicrobial therapy. We prospectively evaluated diabetic patients with non-limb-threatening lower-extremity infections not yet treated with antibiotics. The patients were randomized to outpatient treatment with oral clindamycin hydrochloride or cephalexin for 2 weeks and evaluated every 3 to 7 days. In 56 assessable patients, curettage yielded a mean of 2.1 microorganisms. Aerobic gram-positive cocci were isolated in 50 cases (89%), and were the sole pathogen in 21 (42%) of these. Aerobic gram-negative bacilli and anaerobes were isolated in 20 (36%) and 7 (13%) cases, respectively, and almost always in polymicrobial infections. Fifty-one infections (91%) were eradicated, 42 (75%) after 2 weeks of treatment; only 5 (9%) were initially treatment failures, and 3 (5%) were subsequently cured with further outpatient oral antibiotic treatment. After a mean follow-up of 15 months, no further treatment was required in 43 (84%) of the cured patients. Previously untreated lower-extremity infections in diabetic patients are usually caused by aerobic gram-positive cocci, and generally respond well to outpatient management with oral antibiotic therapy.
Similar articles
-
Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.J Microbiol Immunol Infect. 2007 Feb;40(1):39-44. J Microbiol Immunol Infect. 2007. PMID: 17332905
-
A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.Am Surg. 1986 Sep;52(9):467-71. Am Surg. 1986. PMID: 3530075 Clinical Trial.
-
Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.Am J Med. 1987 Apr 27;82(4A):262-5. Am J Med. 1987. PMID: 3555045 Clinical Trial.
-
The diabetic foot. Soft tissue and bone infection.Infect Dis Clin North Am. 1990 Sep;4(3):409-32. Infect Dis Clin North Am. 1990. PMID: 2212597 Review.
-
Microbiology and antimicrobial therapy of diabetic foot infections.Clin Podiatr Med Surg. 1990 Jul;7(3):467-81. Clin Podiatr Med Surg. 1990. PMID: 2205347 Review.
Cited by
-
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.J Clin Microbiol. 2007 Sep;45(9):2819-28. doi: 10.1128/JCM.00551-07. Epub 2007 Jul 3. J Clin Microbiol. 2007. PMID: 17609322 Free PMC article.
-
Risk factors for primary major amputation in diabetic patients.Sao Paulo Med J. 2006 Mar 2;124(2):66-70. doi: 10.1590/s1516-31802006000200004. Sao Paulo Med J. 2006. PMID: 16878188 Free PMC article.
-
New treatments for diabetic neuropathic foot ulceration: views from a wound healing unit.Curr Diab Rep. 2003 Dec;3(6):468-74. doi: 10.1007/s11892-003-0009-x. Curr Diab Rep. 2003. PMID: 14611742 Review.
-
Effects of macro- and microcirculatory functions on ceftriaxone concentrations in tissues of patients with stage IV peripheral arterial occlusive disease.Antimicrob Agents Chemother. 1995 Jan;39(1):15-9. doi: 10.1128/AAC.39.1.15. Antimicrob Agents Chemother. 1995. PMID: 7695297 Free PMC article.
-
Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to Support Empirical Antibiotic Therapy Decisions in Infected Ischemic Leg Ulcers-A Feasibility Study.J Clin Med. 2024 Oct 18;13(20):6219. doi: 10.3390/jcm13206219. J Clin Med. 2024. PMID: 39458169 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical